Conference Reports for NATAP

The International Liver Congress™ EASL - European Association for the Study of the Liver June 21-24 2023 Back

Long-term Efficacy of Tenofovir Alafenamide in HBeAg-positive and HBeAg-negative Chronic Hepatitis B Patients Treated for up to 8 Years in 2 Phase 3 Studies